Investigator Details
George Kastanis
Investigation Details
Last Issued Date
April 28, 2023
No. of 483’s Issued
since 2023
1
Warning Letters Issued
0
Detailed Analysis
Approach:
George Kastanis'' approach focuses on meticulously scrutinizing GMP compliance, quality systems, and manufacturing protocols. He prioritizes the identification of deficiencies and potential risks to product safety and efficacy during inspections.
Profile:
George Kastanis is a detail-oriented FDA investigator who places a strong emphasis on GMP compliance and quality systems in drug substance and product manufacturing. He is particularly concerned about adherence to standard manufacturing protocols and the adequacy of quality control testing.
Top Process Types:
Unlock Insights from 483s & Stay Audit Ready with FDA Tracker
Monitor FDA Six Systems, Analyse 483s with Observations, Investigators & Companies
Get Started Now